Comments
Abbott hepatitis C drugs bring high cure rates in trial
11.11.2012. | (Reuters) - A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had failed to benefit from standard treatment, as well as very high cure rates for newly treated patients, Abbott said on Saturday....
